Feed aggregator

A new research paper was published in Volume 12 of Oncoscience on November 7, 2025, titled "Temporal trends and disparities in sudden cardiac death among colorectal cancer patients: A nationwide study."

Researchers investigate how soybean oil may disrupt fat metabolism to potentially increase the risk of obesity.

Researchers compare the efficacy of e-visits in clinical settings where other types of visits are available.

A UK study reveals pregnant women's use of alcohol-free drinks, highlighting safety concerns and the need for clearer guidance from healthcare professionals.

Tackling a common childhood virus could open the door to preventing bladder cancer, according to new research funded by Kidney Research UK and York Against Cancer.

University at Buffalo researchers have shown that preloading Instacart online grocery carts with healthy ingredients could be a useful tool for improving the diets of families with young kids at risk for obesity.

A major new study by UCL researchers has revealed the challenges faced by London's 1.3m night workers, including pay inequality, health problems, transport difficulties, safety concerns and a lack of workplace dignity.

In a revelatory Genomic Press Interview published today in Brain Medicine, Dr. Paul Lucassen, full professor at the University of Amsterdam and leader of the Brain Plasticity group, shares his scientific journey that helped transform our understanding of how adult brains adapt to challenge and change.

An international research team led by the Medical University of Vienna has shown that continuous glucose monitoring (CGM) in women with gestational diabetes can reduce the risk of a newborn with above-average birth weight.

High-flying mosquitoes in West Africa are carriers of multiple pathogens, including West Nile virus, highlighting risks in vector-borne disease management.

New research by experts at the University of Sydney shows that breast density notification is leaving some women confused and anxious about their breast health.

The risk of sudden cardiac death is higher both for people with type 1 and type 2 diabetes, according to a large study published in the European Heart Journal today (Thursday). The increase in risk is especially noticeable among younger adults.

People with impaired kidney function have higher levels of Alzheimer's biomarkers in their blood, but not an increased risk of dementia, according to a study published December 3, 2025, in Neurology®, the medical journal of the American Academy of Neurology.

Since the human immunodeficiency virus (HIV) was identified in 1983, roughly 91.4 million people around the world have contracted the virus and an additional 44.1 million have died from related causes.

Cedars-Sinai scientists have developed an experimental drug that repairs DNA and serves as a prototype for a new class of medications that fix tissue damage caused by heart attack, inflammatory disease or other conditions.

A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors-such as empagliflozin (Jardiance) and dapagliflozin (Farxiga)-or glucagon-like peptide-1 (GLP-1) receptor agonists-such as semaglutide (Ozempic) and liraglutide (Victoza)-experience slower progression of frailty over one year compared with those starting other diabetes medications.

Quicker access to bleeding control interventions taught in the American College of Surgeons (ACS) Stop the Bleed program could have prevented the deaths of numerous homicide victims in Maryland, according to a first-of-its-kind analysis published in the Journal of the American College of Surgeons (JACS).

Neutrophils are the most abundant immune cells in the body and the first to respond to infection or tissue damage.

The dark web – a hidden corner of the internet accessed through privacy-preserving tools like the Tor browser – operates beyond the reach of traditional search engines and public platforms.

In November 2018, retailers in Massachusetts began selling recreational cannabis to adults 21 years and older.